Quantcast

Latest pharmaceutical industry Stories

2014-09-08 12:29:49

WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, the generic version of Hospira's Precedex(®) Injection. Par immediately resumed shipping after a U.S. District Court lifted a temporary restraining order that was issued in August at Hospira's request. Last month, Par received final approval from the U.S. Food and Drug Administration...

2014-09-08 12:28:15

PISA, Italy and HONG KONG, September 8, 2014 /PRNewswire/ -- Abiogen Pharma S.p.A. and Lee's Pharmaceutical Holdings Limited jointly announced the agreement for License, Distribution and Supply for marketing of Thorens(R) Cholecalciferol (or vitamin D3) throughout China, Hong Kong, Macau and Taiwan. Under the terms of this agreement, Abiogen granted Lee's an exclusive license and right for registering, importing, marketing, distributing and selling the Cholecalciferol...

2014-09-08 12:27:55

DALLAS, September 8, 2014 /PRNewswire/ -- According to the new market research report "Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer) & End-user (Pharmaceutical Companies, Reference Lab)- Global Trends & Forecasts to 2019", published by MarketsandMarkets, the global Companion Diagnostics Market is expected to reach $8,730.7 Million by 2019 from $3136.9 Million in...

2014-09-08 12:24:43

New report reveals positive outlook for pharmaceutical industry and key insights into current trends PHILADELPHIA, Sept. 8, 2014 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released its annual synopsis of pharmaceutical industry trends in its 2014 Pharmaceutical R&D Factbook, compiled by CMR International, a Thomson Reuters business and world leader in...

2014-09-08 08:31:56

ELLICOTT CITY, Md., Sept. 8, 2014 /PRNewswire/ -- RxTrials, a leading international Investigative Site Network (ISN) and consulting firm, has named Yvonne McCracken, MPH to the position of Vice President of Clinical Operations and Compliance. McCracken, who has 22 years' experience owning and managing sites, will be responsible for ensuring ongoing operational excellence from RxTrials' network of 15 sites in a diverse range of specialty areas. "Yvonne is a very well-known and...

2014-09-08 08:31:07

BOSTON, Sept. 8, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that Merck Serono has completed a routine license renewal for CRINONE in one of its biggest markets. CRINONE is Columbia's largest revenue stream and shipments to this high-growth, high-volume market were...

2014-09-08 08:31:01

BETHESDA, Md., Sept. 8, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Linda F. Powers, CEO, will present at 2:05 pm on Tuesday, September 9, 2014, in the Holmes I Salon at the Palace Hotel in New York as part of the Rodman & Renshaw 16(th) Annual Global Investment Conference. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO...

2014-09-08 08:30:23

SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company dedicated to delivering high quality and novel medicines to physicians and patients at accessible prices, today announced the appointment of William H. Nelson to its Board of Directors, effective September 4, 2014. Mr. Nelson served as the President and Chief Executive Officer of Intermountain Healthcare, an integrated nonprofit healthcare system with 160...

2014-09-08 08:30:20

- Data show improvements in hemodynamic parameters and exercise capacity SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported top-line results from a Phase 2 study of AIR001 (sodium nitrite) inhalation solution for the treatment of pulmonary arterial hypertension (PAH). Mast obtained the rights to the AIR001 program through its acquisition of privately-held Aires Pharmaceuticals, Inc. earlier this year. In the primary efficacy analysis...

2014-09-08 08:29:59

Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease TORONTO, Sept. 8, 2014 /CNW/ - Janssen Inc. (Janssen) today announced it has signed an agreement, facilitated by the Johnson & Johnson Innovation center in California, with the University of Toronto's Centre for Collaborative Drug Research (CCDR) to form an open-source collaboration focused on novel therapeutic approaches to the treatment and management of mood disorders and Alzheimer's disease. The...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'